Technology News and Research

RSS

Transcend second quarter revenue increases 38% to $30,662,000

Transcend Services, Inc., a leading provider of clinical documentation solutions to the U.S. healthcare market, today announced its unaudited financial results for the second quarter ended June 30, 2011.

4 Aug 2011

SXC second quarter revenue increases 153% to $1.2 billion

SXC Health Solutions Corp., a leading provider of technology and pharmacy benefit management services, announces its financial results for the three-month and six-month periods ended June 30, 2011.

4 Aug 2011

Gold nanoparticles for rapid, accurate diagnosis of flu

Arriving at a rapid and accurate diagnosis is critical during flu outbreaks, but until now, physicians and public health officials have had to choose between a highly accurate yet time-consuming test or a rapid but error-prone test.

4 Aug 2011

Technology-enabled pharmacists to make house calls

The University of Rhode Island's College of Pharmacy is pairing home visits from pharmacists with the latest technology, providing instant access to a patient's medical history and medications, all in an effort to reduce hospital readmissions.

4 Aug 2011

Imaging Diagnostic Systems to showcase CT Laser Breast imaging system at FIME 2011

Imaging Diagnostic Systems, Inc., a pioneer in optical breast imaging announced today that it will be exhibiting its CT Laser Breast imaging (CTLM) system at the FIME 2011 conference August 10-12, 2011 in Miami Beach, Florida. IDSI's Head of Clinical Research, Dr Jose Cineros will be a feature speaker at the exhibition.

4 Aug 2011

Study: Chronic mitral valve disease similar in humans and dogs

For more than 15 years, Kansas State University researcher Michele Borgarelli has studied heart diseases in man's best friend.

4 Aug 2011

NSF awards WSU researcher CAREER grant to develop neural implants

Neural implants have the potential to treat disorders and diseases that typically require long-term treatment, such as blindness, deafness, epilepsy, spinal cord injury, and Alzheimer's and Parkinson's. However, implantable devices have been problematic in clinical applications because of bodily reactions that limit device functioning time.

4 Aug 2011

IntegenX's RapidHIT Human Identification Systems now include Promega's STR amplification reagents

IntegenX Inc. and Promega Corporation today announced that commercial deliveries of RapidHIT™ 200 Human Identification Systems will include Promega's nucleic acid purification and short tandem repeat (STR) amplification reagents.

4 Aug 2011

Innovative delivery systems and methods to treat breast cancer

In their lifetime, women have more than a 12 percent risk of being diagnosed with breast cancer. 1 This week, research on novel approaches to breast cancer treatment is being presented at the Era of Hope (EOH) conference, a scientific meeting hosted by the Department of Defense Breast Cancer Research Program (BCRP).

4 Aug 2011

SWHR congressional briefing highlights health issues facing women veterans today

The physical and mental health problems affecting women veterans are a major issue within the Department of Veterans Affairs (VA) and the Department of Defense, and the catalyst for the Society for Women's Health Research (SWHR) congressional briefing, Women Veteran's Health: Sexx Matters held on Tuesday, August 2.

4 Aug 2011

QUT researchers develop new customised IT business management system

A new customised IT business management system developed by Queensland University of Technology (QUT) researchers and capable of improving the scheduling of resources and workflow in surgical theatres has been successfully demonstrated in a German hospital.

4 Aug 2011

Vitamin C helps identify more aggressive or treatment resistant tumours

CANCER RESEARCH UK scientists have developed a new imaging technique that uses vitamin C to detect cancers likely to be more aggressive or resistant to treatment, according to a study published in the Journal of the American Chemical Society today.

4 Aug 2011

Avaxia receives BARDA contract to develop new radiation mitigation drug

Avaxia Biologics, Inc., a privately-held biotech company developing oral antibody drugs that act locally within the gastrointestinal tract, announced today it was awarded a contract with the Biomedical Advanced Research and Development Authority (BARDA), for the research and development of an oral antibody therapy to mitigate the gastrointestinal damage that follows radiation exposure that might occur after a nuclear incident.

4 Aug 2011

New urine test can aid in early detection of prostate cancer

A new urine test can help aid early detection of and treatment decisions about prostate cancer, a study from the University of Michigan Comprehensive Cancer Center and the Michigan Center for Translational Pathology finds.

4 Aug 2011

AMIA expresses concerns about HHS proposed rule

AMIA, the association for informatics professionals in biomedicine and health care, expressed its concerns to the U.S. Department of Health and Human Services (HHS) about a proposed rule that would modify the HIPAA Privacy Rules for accounting of disclosures.

4 Aug 2011

NIH, NanoBio sign licensing agreement to develop vaccine against RSV infections

NanoBio Corporation today announced a licensing agreement with the National Institutes of Health (NIH) that represents a significant step forward in developing the first vaccine to protect against respiratory syncytial virus (RSV) infections.

4 Aug 2011

ImmunoCellular receives new patent for ICT-69 to treat multiple myeloma, ovarian cancer

ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, announced the issuance of a patent in France and the United Kingdom relating to the treatment and detection of multiple myeloma and ovarian cancer.

4 Aug 2011

Virginia Tech to develop, implement and evaluate food security for Southern Appalachians

While the popularity of locally and regionally grown food is on the rise among Americans, food accessibility remains a major concern for those with limited financial resources.

4 Aug 2011

Hopkins stem cell research to examine how gene variants cause blood clotting disorders

Johns Hopkins scientists have launched a pioneering research program to create, for the first time, human platelet cells from stem cells in order to study inherited blood clotting abnormalities ranging from clots that cause heart attacks and stroke to bleeding disorders.

4 Aug 2011

ImmunoGen revenues increase to $19.3 million for fiscal year 2011

ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today reported financial results for the three-month period and fiscal year ended June 30, 2011.

4 Aug 2011